ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin’s Potential to Transform the Treatment of Retinal Disorders September 6, 2010 By Bio-Medicine.Org ‘/>”/> SOURCE